B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 6, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2015-12-21
DOI
10.3389/fimmu.2015.00642
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Humoral autoimmunity: A failure of regulatory T cells?
- (2015) Tessa Dhaeze et al. AUTOIMMUNITY REVIEWS
- Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
- (2015) An Goris et al. BRAIN
- Regulatory plasma cells
- (2015) Simon Fillatreau CURRENT OPINION IN PHARMACOLOGY
- IFN-β Treatment Requires B Cells for Efficacy in Neuroautoimmunity
- (2015) Ryan D. Schubert et al. JOURNAL OF IMMUNOLOGY
- B Cell Antigen Presentation Is Sufficient To Drive Neuroinflammation in an Animal Model of Multiple Sclerosis
- (2015) Chelsea R. Parker Harp et al. JOURNAL OF IMMUNOLOGY
- Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis
- (2015) Tessa Dhaeze et al. JOURNAL OF IMMUNOLOGY
- ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis
- (2015) Robert C. Sergott et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis
- (2015) Giulia Mallucci et al. PROGRESS IN NEUROBIOLOGY
- Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use
- (2015) Eva Havrdova et al. Therapeutic Advances in Neurological Disorders
- Dimethyl fumarate in the treatment of relapsing–remitting multiple sclerosis: an overview
- (2015) Roberto Bomprezzi Therapeutic Advances in Neurological Disorders
- Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy
- (2014) Clemens Warnke et al. ANNALS OF NEUROLOGY
- Targets of the humoral autoimmune response in multiple sclerosis
- (2014) Judith Fraussen et al. AUTOIMMUNITY REVIEWS
- Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations
- (2014) Yusei Miyazaki et al. CLINICAL IMMUNOLOGY
- Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis
- (2014) Laure Michel et al. CLINICAL IMMUNOLOGY
- Update on Disease-Modifying Treatments for Multiple Sclerosis
- (2014) Michael D. Carrithers CLINICAL THERAPEUTICS
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- (2014) Amit Bar-Or et al. DRUGS
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- (2014) Amit Bar-Or EXPERIMENTAL NEUROLOGY
- Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemia
- (2014) John L Reagan et al. Future Oncology
- Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL
- (2014) M. J. Benson et al. JOURNAL OF IMMUNOLOGY
- Resting Human Memory B Cells Are Intrinsically Programmed for Enhanced Survival and Responsiveness to Diverse Stimuli Compared to Naive B Cells
- (2014) K. L. Good et al. JOURNAL OF IMMUNOLOGY
- Sperm-Associated Antigen 16 Is a Novel Target of the Humoral Autoimmune Response in Multiple Sclerosis
- (2014) Laura de Bock et al. JOURNAL OF IMMUNOLOGY
- Immunological biomarkers identifying natalizumab-treated multiple sclerosis patients at risk of progressive multifocal leukoencephalopathy
- (2014) Federico Serana et al. JOURNAL OF NEUROIMMUNOLOGY
- B1 cells are unaffected by immune modulatory treatment in remitting–relapsing multiple sclerosis patients
- (2014) Damiano Rovituso et al. JOURNAL OF NEUROIMMUNOLOGY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Christian Confavreux et al. LANCET NEUROLOGY
- Newly produced T and B lymphocytes and T-cell receptor repertoire diversity are reduced in peripheral blood of fingolimod-treated multiple sclerosis patients
- (2014) M Chiarini et al. Multiple Sclerosis Journal
- Decreased Dicer expression is linked to increased expression of co-stimulatory molecule CD80 on B cells in multiple sclerosis
- (2014) Latt Latt Aung et al. Multiple Sclerosis Journal
- Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF
- (2014) Clemens Warnke et al. Multiple Sclerosis Journal
- Differential effects of fingolimod on B-cell populations in multiple sclerosis
- (2014) Masakazu Nakamura et al. Multiple Sclerosis Journal
- Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis
- (2014) Sandra Amor et al. Multiple Sclerosis Journal
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
- (2014) Ping Shen et al. NATURE
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study
- (2014) Nele Claes et al. PLoS One
- Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
- (2014) A. Palanichamy et al. Science Translational Medicine
- B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
- (2014) J. N. H. Stern et al. Science Translational Medicine
- B cells in MS and NMO: pathogenesis and therapy
- (2014) Markus Krumbholz et al. Seminars in Immunopathology
- The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis
- (2014) Sara J. Ireland et al. JAMA Neurology
- Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity
- (2014) Klaus Lehmann-Horn et al. Annals of Clinical and Translational Neurology
- In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses
- (2013) Jaishree Bankoti et al. ANNALS OF NEUROLOGY
- Immunoadsorption in steroid-refractory multiple sclerosis: Clinical experience in 60 patients
- (2013) Franz Heigl et al. ATHEROSCLEROSIS SUPPLEMENTS
- Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis
- (2013) J. Sellner et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Which Immune Cells Matter? The Immunopathogenesis of Multiple Sclerosis
- (2013) Bieke Broux et al. CRITICAL REVIEWS IN IMMUNOLOGY
- B-cell biology and development
- (2013) Kathrin Pieper et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Specific peripheral B cell tolerance defects in patients with multiple sclerosis
- (2013) Tuure Kinnunen et al. JOURNAL OF CLINICAL INVESTIGATION
- MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
- (2013) Nicolas Molnarfi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- B Cells Promote Induction of Experimental Autoimmune Encephalomyelitis by Facilitating Reactivation of T Cells in the Central Nervous System
- (2013) E. R. Pierson et al. JOURNAL OF IMMUNOLOGY
- Identification of coronin-1a as a novel antibody target for clinically isolated syndrome and multiple sclerosis
- (2013) Myrthe Rouwette et al. JOURNAL OF NEUROCHEMISTRY
- Autoantigen induced clonal expansion in immortalized B cells from the peripheral blood of multiple sclerosis patients
- (2013) Judith Fraussen et al. JOURNAL OF NEUROIMMUNOLOGY
- Effect of interferon beta-1a on B7.1 and B7.2 B-cell expression and its impact on T-cell proliferation
- (2013) Hui Huang et al. JOURNAL OF NEUROIMMUNOLOGY
- The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro
- (2013) Li Li et al. JOURNAL OF NEUROIMMUNOLOGY
- Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial
- (2013) Patrick Vermersch et al. Multiple Sclerosis Journal
- Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis
- (2013) A. Bar-Or et al. NEUROLOGY
- Natalizumab Therapy for Multiple Sclerosis
- (2013) Jens Kuhle et al. SEMINARS IN NEUROLOGY
- Teriflunomide in relapsing multiple sclerosis: therapeutic utility
- (2013) Mark S. Freedman Therapeutic Advances in Chronic Disease
- B Cell Repopulation After Alemtuzumab Induction-Transient Increase in Transitional B Cells and Long-Term Dominance of Naïve B Cells
- (2012) S. Heidt et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis
- (2012) Luisa M. Villar ARCHIVES OF NEUROLOGY
- Antibody-independent B cell effector functions in relapsing remitting Multiple Sclerosis: Clues to increased inflammatory and reduced regulatory B cell capacity
- (2012) Sara J. Ireland et al. AUTOIMMUNITY
- Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells
- (2012) T. Kinnunen et al. BLOOD
- Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
- (2012) Christina Elliott et al. BRAIN
- New treatments and treatment goals for patients with relapsing-remitting multiple sclerosis
- (2012) Edward J. Fox et al. CURRENT OPINION IN NEUROLOGY
- A role for Th17 cells in the regulation of tertiary lymphoid follicles
- (2012) Jane L. Grogan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- B cell exchange across the blood-brain barrier in multiple sclerosis
- (2012) H.-Christian von Büdingen et al. JOURNAL OF CLINICAL INVESTIGATION
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome
- (2012) Myrthe Rouwette et al. JOURNAL OF NEUROCHEMISTRY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis
- (2012) Chao Quan et al. Multiple Sclerosis Journal
- Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy
- (2012) A Harrer et al. Multiple Sclerosis Journal
- Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS
- (2012) Robert J Fox et al. Multiple Sclerosis Journal
- Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
- (2012) Ayumi Yoshizaki et al. NATURE
- Alemtuzumab more effective than interferon -1a at 5-year follow-up of CAMMS223 Clinical Trial
- (2012) A. J. Coles et al. NEUROLOGY
- Fingolimod for Multiple Sclerosis
- (2012) Daniel Pelletier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphocyte Subsets Show Different Response Patterns to In Vivo Bound Natalizumab—A Flow Cytometric Study on Patients with Multiple Sclerosis
- (2012) Andrea Harrer et al. PLoS One
- Pre-Existing T- and B-Cell Defects in One Progressive Multifocal Leukoencephalopathy Patient
- (2012) Alessandra Sottini et al. PLoS One
- Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis
- (2012) Natalie A Carter et al. ARTHRITIS RESEARCH & THERAPY
- Natalizumab
- (2012) Richard Rudick et al. JAMA Neurology
- Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial
- (2011) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells
- (2011) Aharon Kessel et al. AUTOIMMUNITY REVIEWS
- CD49d blockade by natalizumab therapy in patients with multiple sclerosis increases immature B-lymphocytes
- (2011) J-F Lesesve et al. BONE MARROW TRANSPLANTATION
- Treatment of multiple sclerosis with Anti-CD20 antibodies
- (2011) Barbara Barun et al. CLINICAL IMMUNOLOGY
- Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis
- (2011) Raquel Planas et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- B cells undergo unique compartmentalized redistribution in multiple sclerosis
- (2011) Jürgen Haas et al. JOURNAL OF AUTOIMMUNITY
- Pharmacodynamic Effects of Steady-State Fingolimod on Antibody Response in Healthy Volunteers: A 4-Week, Randomized, Placebo-Controlled, Parallel-Group, Multiple-Dose Study
- (2011) Craig Boulton et al. JOURNAL OF CLINICAL PHARMACOLOGY
- B Cells as a Therapeutic Target for IFN-β in Relapsing–Remitting Multiple Sclerosis
- (2011) Vinod S. Ramgolam et al. JOURNAL OF IMMUNOLOGY
- Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients
- (2011) Mario Skarica et al. JOURNAL OF NEUROIMMUNOLOGY
- Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin
- (2011) Birgit Obermeier et al. JOURNAL OF NEUROIMMUNOLOGY
- Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission
- (2011) Stephanie Knippenberg et al. JOURNAL OF NEUROIMMUNOLOGY
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
- (2011) M. C. Kowarik et al. NEUROLOGY
- Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis
- (2011) M. Mehling et al. NEUROLOGY
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity
- (2010) Martin S. Weber et al. ANNALS OF NEUROLOGY
- Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: Results of a randomized, double-blind, placebo-controlled, phase I/II study
- (2010) Mikkel Østergaard et al. ARTHRITIS AND RHEUMATISM
- Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
- (2010) Y. Iwata et al. BLOOD
- Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4+ T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein
- (2010) Christopher T. Harp et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Effects of Natalizumab on Circulating B Cells, T Regulatory Cells and Natural Killer Cells
- (2010) Norman Putzki et al. EUROPEAN NEUROLOGY
- Ofatumumab, a human anti-CD20 monoclonal antibody
- (2010) Anders Österborg EXPERT OPINION ON BIOLOGICAL THERAPY
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10-Producing Regulatory B Cells
- (2010) M. Yang et al. JOURNAL OF IMMUNOLOGY
- Human Polyomavirus JC (JCV) Infection of Human B Lymphocytes: A Possible Mechanism for JCV Transmigration across the Blood‐Brain Barrier
- (2010) Moti L. Chapagain et al. JOURNAL OF INFECTIOUS DISEASES
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proinflammatory T helper type 17 cells are effective B-cell helpers
- (2010) M. Mitsdoerffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Atacicept: targeting B cells in multiple sclerosis
- (2010) Hans-Peter Hartung et al. Therapeutic Advances in Neurological Disorders
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Immunomodulatory effects of Vitamin D in multiple sclerosis
- (2009) J. Correale et al. BRAIN
- FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
- (2009) Volker Brinkmann BRITISH JOURNAL OF PHARMACOLOGY
- Ocrelizumab: a step forward in the evolution of B-cell therapy
- (2009) Fariha Kausar et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
- (2009) Sara A. J. Thompson et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results
- (2009) G. Comi et al. Multiple Sclerosis Journal
- Interferon- mechanisms of action in multiple sclerosis
- (2009) S. Dhib-Jalbut et al. NEUROLOGY
- Oral fingolimod (FTY720) in multiple sclerosis: Two-year results of a phase II extension study
- (2009) P. O'Connor et al. NEUROLOGY
- Memory and naïve B-cell subsets in patients with multiple sclerosis
- (2009) Masaaki Niino et al. NEUROSCIENCE LETTERS
- Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium
- (2009) Frances Humby et al. PLOS MEDICINE
- Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
- (2008) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- T Follicular Helper (TFH) Cells in Normal and Dysregulated Immune Responses
- (2008) Cecile King et al. Annual Review of Immunology
- Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity
- (2008) M. Krumbholz et al. BRAIN
- Rituximab: Beyond Simple B Cell Depletion
- (2008) A. Kessel et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin‐specific antibodies
- (2008) Hans‐Christian von Büdingen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
- (2008) Koichi Yanaba et al. IMMUNITY
- Regulatory B cells as inhibitors of immune responses and inflammation
- (2008) Jean-David Bouaziz et al. IMMUNOLOGICAL REVIEWS
- Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP
- (2008) Chris J. Hedegaard et al. IMMUNOLOGY
- A review of the current use of rituximab in autoimmune diseases
- (2008) Hakan M. Gürcan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
- (2008) Takashi Matsushita et al. JOURNAL OF CLINICAL INVESTIGATION
- A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis
- (2008) Howard L. Weiner JOURNAL OF NEUROLOGY
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
- (2008) Daniel D Mikol et al. LANCET NEUROLOGY
- Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis
- (2008) M. Krumbholz et al. NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More